Federal contract award
75N98C24F00009
10X GENOMICS, INC.:1279204 [24-002341]. THESE REAGENTS WILL BE USED TO PERFORM SNRNASEQ TO UNDERSTAND THE DIFFERENTIAL GENE EXPRESSION OF COCHLEA FROM CONTROL AND CISPLATIN-TREATED MICE.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INTITUTES OF HEALTH NIDCD |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6640 — Laboratory Equipment and Supplies |
| Parent award / vehicle | 75N98022A00032 |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $22.5K |
| Current contract value | $22.5K |
| Potential contract value / ceiling | $22.5K |
| Start date | Apr 13, 2022 |
| Current end date | Jan 31, 2025 |
| Potential end date | Jan 31, 2025 |
| Latest award activity | Aug 2, 2024 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 2, 2024 | 0 | $22.5K | 10X GENOMICS, INC.:1279204 [24-002341]. THESE REAGENTS WILL BE USED TO PERFORM SNRNASEQ TO UNDERSTAND THE DIFFERENTIAL GENE EXPRESSION OF COCHLEA FROM CONTROL AND CISPLATIN-TREATED MICE. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.